BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34795760)

  • 1. Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-
    Cai BQ; Chen WM; Zhao J; Hou W; Tang JC
    J Oncol; 2021; 2021():9355555. PubMed ID: 34795760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway.
    Cai BQ; Chen WM; Chen MW; Chen YH; Tang JC
    Open Life Sci; 2023; 18(1):20220790. PubMed ID: 38027228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction.
    Liu B; Xu T; Xu X; Cui Y; Xing X
    Mol Cell Biochem; 2018 Dec; 449(1-2):285-294. PubMed ID: 29761248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition.
    Chen WM; Hu QY; Hou W; Chen MW; Chen YH; Tang JC
    Oncol Lett; 2023 Oct; 26(4):443. PubMed ID: 37720674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK.
    Zhou S; Li Y; Lu J; Chen C; Wang W; Wang L; Zhang Z; Dong Z; Tang F
    Am J Cancer Res; 2019; 9(3):511-528. PubMed ID: 30949407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin/TCF4 Complex-Mediated Induction of the
    Aono S; Hatanaka A; Hatanaka A; Gao Y; Hippo Y; Taketo MM; Waku T; Kobayashi A
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31288376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway.
    La X; Zhang L; Li Z; Li H; Yang Y
    J Agric Food Chem; 2019 Mar; 67(9):2510-2518. PubMed ID: 30741544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxymatrine reverses 5-fluorouracil resistance by inhibition of colon cancer cell epithelial-mesenchymal transition and NF-κB signaling
    Liang L; Wu J; Luo J; Wang L; Chen ZX; Han CL; Gan TQ; Huang JA; Cai ZW
    Oncol Lett; 2020 Jan; 19(1):519-526. PubMed ID: 31897166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.
    Wang BD; Kline CL; Pastor DM; Olson TL; Frank B; Luu T; Sharma AK; Robertson G; Weirauch MT; Patierno SR; Stuart JM; Irby RB; Lee NH
    Mol Cancer; 2010 Apr; 9():98. PubMed ID: 20433755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New uracil analog U-332 is an inhibitor of NF-κB in 5-fluorouracil-resistant human leukemia HL-60 cell line.
    Długosz-Pokorska A; Pięta M; Kędzia J; Janecki T; Janecka A
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):18. PubMed ID: 32122395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf3 Functions Reversely as a Tumorigenic to an Antitumorigenic Transcription Factor in Obese Mice.
    Waku T; Iwami T; Masuda H; Hirose S; Aketa I; Kobayashi A
    Tohoku J Exp Med; 2022 Dec; 259(1):1-8. PubMed ID: 36328531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.
    Yang Y; Ma L; Xu Y; Liu Y; Li W; Cai J; Zhang Y
    Cell Death Dis; 2020 Jun; 11(6):477. PubMed ID: 32581212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
    Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
    PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.
    Voboril R; Hochwald SN; Li J; Brank A; Weberova J; Wessels F; Moldawer LL; Camp ER; MacKay SL
    J Surg Res; 2004 Aug; 120(2):178-88. PubMed ID: 15234211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
    Xu GY; Tang XJ
    Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.